Piscataway, New Jersey 08854


There is a high incidence among the first degree relatives of the carcinoid patients, indicating the involvement of genetic components in its initiation and pathogenesis.

Study summary:

This proposed pilot study will conduct detailed interviews into the medical, environmental, and family histories and to collect blood specimen to obtain DNA. The Blood specimen and DNA will be processed by the Rutgers University Cell and DNA Repository (RUCDR) to rule out Familial Multiple Endocrine Neoplasia (MEN 1), and succinate dehydrogenase complex, subunit D (SDHD), gene inactivation thought to be associated with different types of carcinoid cancer.


Inclusion Criteria: 1. Over the age of 18 years 2. More than one ,member of a family with a history of biopsy confirmed carcinoid tumor 3. English speaking 4. Mentally and emotionally capable of answering questions 5. Willing and available for study participation 6. At least one other family member with carcinoid tumor Exclusion Criteria: 1. If you are under the age of 18 years, 2. If you are unable to understand or unable to provide informed consent, 3. If you have a psychological condition (i.e. depression, anxiety disorder, substance abuse, etc.) which might cause you significant problems in dealing with test results.



Primary Contact:

Principal Investigator
Nancy Gardner, PhD
Rutgers University

Nancy Gardner, PhD
Phone: 813-731-0894
Email: gardnern@rutgers.edu

Backup Contact:

Email: Shao@Biology.Rutgers.Edu
Changshun Shao, PhD

Location Contact:

Piscataway, New Jersey 08854
United States

Changshun Shao, PhD
Phone: 732-445-5406
Email: shao@biology.rutgers.edu

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.